NCT07093528 A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
| NCT ID | NCT07093528 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Heart Failure With Preserved Ejection Fraction |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-10-16 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2025-10-16 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Eligibility Criteria
Inclusion Criteria: * Age ≥18 * Enrollment in main CS-reducer HFPEF study IRB# 25-002292 Exclusion Criteria: * Metal implants that are not suitable for MRI * Inability or unwillingness of individual to give written informed consent.
Contact & Investigator
Claire Raphael, M.B.B.S., Ph.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07093528 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure With Preserved Ejection Fraction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07093528 currently recruiting?
Yes, NCT07093528 is actively recruiting participants. Contact the research team at albers.diana2@mayo.edu for enrollment information.
Where is the NCT07093528 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07093528 clinical trial?
NCT07093528 is sponsored by Mayo Clinic. The principal investigator is Claire Raphael, M.B.B.S., Ph.D. at Mayo Clinic. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.